Bobby McMillin is named as a lobbyist on federal disclosure filings for 15 clients through Arnold & Porter Kaye Scholer LLP. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Pharmacy and Education.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Pharmacy, Medical/Disease Research/Clinical Labs, Health Issues |
| NEW YORK BLOOD CENTER ENTERPRISES | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Health Issues |
| CALBRIGHT COLLEGE | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Education, Budget/Appropriations |
| SUMITOMO PHARMA AMERICA, INC. | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| RECORDATI RARE DISEASES INC. | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| NOVO NORDISK, INC. | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Consumer Issues/Safety/Products, Medicare/Medicaid, Pharmacy |
| GENETIX BIOTHERAPEUTICS, INC. | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| UNICYCIVE THERAPEUTICS INC. | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Health Issues |
| REGENERON PHARMACEUTICALS, INC. | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Health Issues |
| NEURALINK CORP. | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| ESTEVE PHARMACEUTICALS, LLC | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| EXELIXIS, INC. | ARNOLD & PORTER KAYE SCHOLER LLP | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues |
| NEURELIS, INC. | ARNOLD & PORTER KAYE SCHOLER LLP | Q1 2026 | Health Issues |
| NOVO NORDISK A/S | ARNOLD & PORTER KAYE SCHOLER LLP | Q1 2025 | Health Issues, Manufacturing |
| WILLIAM & MARY FOUNDATION | ARNOLD & PORTER KAYE SCHOLER LLP | Q1 2025 | Education, Budget/Appropriations |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 13 | 1 |
| 2025 | 9 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 4 | $4K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Bobby McMillin. See the Capitol Clarity rankings and method.